NPC166993 |
Weisiensin A |
n.a. |
3 |
4 |
NPC235698 |
Aglaroxin A |
n.a. |
5 |
7 |
NPC181594 |
Kamebanin |
n.a. |
37 |
63 |
NPC288598 |
HAFLZKVDLUXIRO-BJGLQNCMSA-N |
n.a. |
0 |
0 |
NPC169605 |
CZRRXJGGUKNLNR-SMEMBOTLSA-N |
n.a. |
5 |
5 |
NPC15362 |
NQABJFRJEKCYEC-GFPDKIFBSA-N |
n.a. |
0 |
0 |
NPC232702 |
SOZZFXSEKXBXFS-NXZHAISVSA-N |
n.a. |
0 |
0 |
NPC474974 |
Aglamide D |
(E)-1-(2-methoxypyrrolidin-1-yl)-3-phenylprop-2-en-1-one |
4 |
4 |
NPC474973 |
Aglamide C |
3-methyl-N-[1-[(E)-3-phenylprop-2-enoyl]pyrrolidin-2-yl]butanamide |
4 |
4 |
NPC140023 |
HHDWASZUEPJCND-FMIVXFBMSA-N |
n.a. |
0 |
0 |
NPC476048 |
Aglamide B |
(E)-3-methylsulfinyl-N-[1-[(E)-3-phenylprop-2-enoyl]pyrrolidin-2-yl]prop-2-enamide |
4 |
4 |
NPC41436 |
ZDLUERJVCJYBIT-IIRAHQKESA-N |
n.a. |
0 |
0 |
NPC475292 |
Edulirin A |
n.a. |
4 |
4 |
NPC172128 |
N,N'-(Butane-1,4-Diyl)Bis(2-Phenylacetamide) |
2-phenyl-N-[4-[(2-phenylacetyl)amino]butyl]acetamide |
5 |
5 |
NPC236089 |
Pannellin |
n.a. |
5 |
12 |
NPC5674 |
19,20-Dehydroedulisone A |
methyl (6R,7S,8R)-10-methoxy-6-(4-methoxyphenyl)-8-[(2R)-2-(3-methylbut-2-enoylamino)pyrrolidine-1-carbonyl]-9-oxo-7-phenyl-7,8-dihydro-[1,3]dioxolo[4,5-h][1]benzoxepine-6-carboxylate |
4 |
4 |
NPC110070 |
5-Hydroxy-3,6,7-Trimethoxy-2-(4-Methoxyphenyl)Chromen-4-One |
5-hydroxy-3,6,7-trimethoxy-2-(4-methoxyphenyl)chromen-4-one |
67 |
72 |
NPC297424 |
TWFHOUXMAZZNJD-GFPDKIFBSA-N |
n.a. |
0 |
0 |
NPC475565 |
Edulirin B |
n.a. |
4 |
4 |
NPC199796 |
HZXIWBLGRBHNQF-HWZCDQJBSA-N |
n.a. |
0 |
0 |
NPC163963 |
SOISFJAFHWJMRU-AWQMTSQZSA-N |
n.a. |
1 |
1 |
NPC475624 |
CKBNTTYCPYJUBL-HMVMMOFVSA-N |
n.a. |
4 |
4 |
NPC475013 |
Aglamide A |
(E)-3-methylsulfanyl-N-[1-[(E)-3-phenylprop-2-enoyl]pyrrolidin-2-yl]prop-2-enamide |
4 |
4 |
NPC173404 |
LNZGSCAHRLPKJP-GQIULXPASA-N |
n.a. |
0 |
0 |
NPC475349 |
Isoedulirin A |
n.a. |
4 |
4 |
NPC258128 |
NDXZPZLQQNLZFC-CPZZKNJMSA-N |
n.a. |
4 |
4 |
NPC257622 |
JKZLKZYPQLSLFH-GFPDKIFBSA-N |
n.a. |
0 |
0 |
NPC475442 |
19,20-Dehydroedulirin A |
n.a. |
4 |
4 |
NPC203501 |
GNZVDICBVAWEHO-WXOYLIDVSA-N |
n.a. |
0 |
0 |